Clinical Laserthermia Systems AB (publ) announced that its acting CEO Dan J. Mogren will go on a planned sick leave on Feb. 10, 2022 until the March 31, 2022. The Board of Directors has appointed Lars-Erik Eriksson, the company CFO and previous CEO, deputy CEO during this period.
Clinical Laserthermia Systems AB
Equities
CLS B
SE0022049920
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.9 SEK | -1.62% |
|
-3.26% | -78.62% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-78.62% | 4.5M | |
-3.69% | 817M | |
-31.56% | 218M | |
0.00% | 126M | |
-38.85% | 70.35M |
- Stock Market
- Equities
- CLS B Stock
- News Clinical Laserthermia Systems AB
- Clinical Laserthermia Systems AB Announces CEO Changes